Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors

von Gupta, Jalaj, Igea, Ana, Papaioannou, Marilena, Lopez-Casas, Pedro Pablo, Llonch, Elisabet, Hidalgo, Manuel, Gorgoulis, Vassilis G., Nebreda, Angel R.
Veröffentlicht in Oncotarget (2015)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET

von Hernández-Agudo, Elena, Mondejar, Tamara, Soto-Montenegro, Maria Luisa, Megías, Diego, Mouron, Silvana, Sanchez, Jesus, Hidalgo, Manuel, Lopez-Casas, Pedro Pablo, Mulero, Francisca, Desco, Manuel, Quintela-Fandino, Miguel
Veröffentlicht in Mol Oncol (2015)

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models

von Céspedes, María Virtudes, Guillén, María José, López-Casas, Pedro Pablo, Sarno, Francesca, Gallardo, Alberto, Álamo, Patricia, Cuevas, Carmen, Hidalgo, Manuel, Galmarini, Carlos María, Allavena, Paola, Avilés, Pablo, Mangues, Ramón
Veröffentlicht in Dis Model Mech (2016)

MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management

von Morcillo, Miguel Ángel, García de Lucas, Ángel, Oteo, Marta, Romero, Eduardo, Magro, Natalia, Ibáñez, Marta, Martínez, Alfonso, Garaulet, Guillermo, Arroyo, Alicia G., López-Casas, Pedro Pablo, Hidalgo, Manuel, Mulero, Francisca, Martínez-Torrecuadrada, Jorge
Veröffentlicht in Contrast Media Mol Imaging (2018)

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data

von Piñeiro-Yáñez, Elena, Reboiro-Jato, Miguel, Gómez-López, Gonzalo, Perales-Patón, Javier, Troulé, Kevin, Rodríguez, José Manuel, Tejero, Héctor, Shimamura, Takeshi, López-Casas, Pedro Pablo, Carretero, Julián, Valencia, Alfonso, Hidalgo, Manuel, Glez-Peña, Daniel, Al-Shahrour, Fátima
Veröffentlicht in Genome Med (2018)